FindTrial
Sign In

Exploratory research for searching for the objective parameters related to study drug efficacy with the imaging data

Exploratory research for searching for the objective parameters related to study drug efficacy with the imaging data - Exploratory research for searching for the objective parameters related to study drug efficacy with the imaging data

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000048578
Enrollment
39
Registered
2022-08-04
Start date
2022-06-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian Gland Dysfunction

Interventions

None listed

Sponsors

Santen Pharmaceutical Co. Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were administered an investigational drug including placebo at study sites during the study period, imaging data was taken, and clinical information was available.

Exclusion criteria

Exclusion criteria: Patients whose imaging data was not taken, or imaging data was not clear, or consent has not been obtained for its use.

Design outcomes

Primary

MeasureTime frame
Morphological change of Meibomian gland and Lid margin before and after treatment—

Countries

Japan

Contacts

Public ContactHiroyuki Shimizu

Santen Pharmaceutical Co. Ltd. Ophthalmology Innovation center

clinical@santen.com06-4802-9339

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026